These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 18084326

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. FOXM1 is an oncogenic mediator in Ewing Sarcoma.
    Christensen L, Joo J, Lee S, Wai D, Triche TJ, May WA.
    PLoS One; 2013; 8(1):e54556. PubMed ID: 23365673
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells.
    Li X, Tanaka K, Nakatani F, Matsunobu T, Sakimura R, Hanada M, Okada T, Nakamura T, Iwamoto Y.
    Int J Cancer; 2005 Sep 01; 116(3):385-94. PubMed ID: 15818598
    [Abstract] [Full Text] [Related]

  • 9. FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells.
    Yang L, Hu HM, Zielinska-Kwiatkowska A, Chansky HA.
    Biochem Biophys Res Commun; 2010 Nov 05; 402(1):129-34. PubMed ID: 20933505
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors.
    Zwerner JP, May WA.
    Oncogene; 2001 Feb 01; 20(5):626-33. PubMed ID: 11313995
    [Abstract] [Full Text] [Related]

  • 13. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.
    Tirado OM, Mateo-Lozano S, Villar J, Dettin LE, Llort A, Gallego S, Ban J, Kovar H, Notario V.
    Cancer Res; 2006 Oct 15; 66(20):9937-47. PubMed ID: 17047056
    [Abstract] [Full Text] [Related]

  • 14. GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein.
    Beauchamp E, Bulut G, Abaan O, Chen K, Merchant A, Matsui W, Endo Y, Rubin JS, Toretsky J, Uren A.
    J Biol Chem; 2009 Apr 03; 284(14):9074-82. PubMed ID: 19189974
    [Abstract] [Full Text] [Related]

  • 15. Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity.
    Balestra T, Manara MC, Laginestra MA, Pasello M, De Feo A, Bassi C, Guerzoni C, Landuzzi L, Lollini PL, Donati DM, Negrini M, Magnani M, Scotlandi K.
    Mol Cancer Ther; 2022 Jan 03; 21(1):58-69. PubMed ID: 34667115
    [Abstract] [Full Text] [Related]

  • 16. A novel role for keratin 17 in coordinating oncogenic transformation and cellular adhesion in Ewing sarcoma.
    Sankar S, Tanner JM, Bell R, Chaturvedi A, Randall RL, Beckerle MC, Lessnick SL.
    Mol Cell Biol; 2013 Nov 03; 33(22):4448-60. PubMed ID: 24043308
    [Abstract] [Full Text] [Related]

  • 17. Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells.
    Miyagawa Y, Okita H, Nakaijima H, Horiuchi Y, Sato B, Taguchi T, Toyoda M, Katagiri YU, Fujimoto J, Hata J, Umezawa A, Kiyokawa N.
    Mol Cell Biol; 2008 Apr 03; 28(7):2125-37. PubMed ID: 18212050
    [Abstract] [Full Text] [Related]

  • 18. EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.
    Kinsey M, Smith R, Iyer AK, McCabe ER, Lessnick SL.
    Cancer Res; 2009 Dec 01; 69(23):9047-55. PubMed ID: 19920188
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.